-The Hindu In a significant development for the pharmaceutical industry, the Supreme Court has rejected multinational Bayer's appeal to block production and sales of the low cost version of its kidney cancer drug, sorafenib tosylate (branded as Nexavar), by Natco Pharmaceuticals. Hyderabad-based Natco was granted the first and to date only compulsory licence (CL) by the government in 2012 to make and sell a patented drug at a fraction of the...
More »SEARCH RESULT
Total Matching Records found : 226
52 more drugs brought under price ceiling
-Business Standard This would be in addition to 348 drugs already under price ceiling The National Pharmaceutical Pricing Authority (NPPA) has capped the prices of another 52 essential drugs, in a move that could impact drug manufacturers Lupin, Cadila Healthcare and Merck. This is in addition to the 348 drugs already under a price ceiling. The majority of the 52 new drugs are antibiotics, painkillers and medicines used for treating cancer and skin...
More »Activists and concerned citizens oppose budget cuts in social sector
-Press Release from Centre for Budget Analysis (CBGA) and Jan Awaaz New Delhi, 29 November 2014: There have been a number of media reports recently around possible cuts in Union Budget allocations for the current fiscal 2014-15 in case of social sector programmes, i.e. reductions in allocations in the Revised Estimates (RE) for 2014-15 as compared to the Budget Estimates (BE) that were made in July this year. This issue deserves...
More »Letter to PM about US-India Bilateral Relations on Intellectual Property
-Kafila.org Dear Prime Minister Modi ji, We, the undersigned, wish to share with you some of our concerns on India's position on intellectual property (IP), particularly in the context of bilateral relations between the United States of America and India. We gather from the US-India Joint Statement dated 30 September 2014 that the Indian Government (a)greeing on the need to foster innovation in a manner that promotes economic growth...
More »Stop prescribing antibiotics for fever and cold, Indian Medical Association will tell doctors -Durgesh Nandan Jha
-The Times of India NEW DELHI: Faced with the scary prospect of losing lives to simple infections in the future, India is finally waking up to the dangers of reckless antibiotic use. The Indian Medical Association, a pan-India voluntary organization of doctors, will on Sunday launch a nationwide awareness programme on overuse of these live-savers, a practice that has led to emergence of drug-resistant organisms. IMA will also ask fellow practitioners to...
More »
